Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synflorix long-term follow-up booster and catch-up study in children aged 36-46 months
2008-003950-14Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2008
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of 10-valent pneumococcal conjugate vaccine in pneumococcal disease (3 arms), sponsored by GSK. Primary endpoint: Antibody concentrations against vaccine pneumococcal serotypes. Started Sep 2008; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2008-003950-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003950-14.